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INTRODUCTION: Pharmaceuticals are an essential component of the medical system for crewed 
missions. Current research has identified decreased stability in space-flown pharmaceuticals 
compared to ground controls, and this presents a significant risk for future exploration-class 
missions where resupply will be limited. While the cause is not known, the elevated ambient carbon 
dioxide (C02) in the spacecraft atmosphere has been postulated as a potential contributing factor. 
The aim of the review was to determine the impact of higher partial pressure of carbon dioxide in 
the atmosphere on pharmaceutical stability from the available literature.  
METHODS: An extensive search was conducted on the Ovid MEDLINE, Ovid EMBASE, Cochrane 
Library (Wiley), Web of Science Core Collections (Clarivate Analytics), PubSpace, and the NASA 
Technical Reports Server (NTRS) databases from the beginning of records to April 6, 2020. Abstract 
screening was performed on the results in a blinded manner by two authors (KP, BC) and secondary 
screening by full text was performed in a blinded manner by another two authors (AY, RV, ES). The 
Aerospace Medicine Systematic Review Group (AMSRG) quality scoring tool was used to assess the 
quality of included documents and NVivo 12 was used to extract data for thematic analysis.  
RESULTS: The systematic review identified a total of four publications of varying quality out of a total 
of 13,385 documents. There was insufficient data to complete a quantitative comparison. A thematic 
analysis was conducted and revealed two overarching themes: 1) Elevated levels of ambient C02 
may be a precipitating factor leading to pharmaceutical degradation and 2) that pharmaceutical 
repackaging may lead to accelerated degradation profiles.  
DISCUSSION: The lack of quality studies in both terrestrial and space environments affirm a 
literature gap in understanding the effect of elevated ambient C02 on pharmaceutical stability. 
Furthermore, space-flown pharmaceuticals are repackaged for missions due to operational purposes 
and there is terrestrial literature reporting limited stability for pharmaceuticals that were 
repackaged on the ground in dosage administration aids. Further studies are needed to elicit the 
individual impact of higher ambient C02 and repackaging on pharmaceutical stability. 
